France (FR)

Impact of normalization, standardization and pre-fit on the success rate of fitting in electrochemical impedance spectroscopy (2021) Pfeiffer N, Jechow M, Wachter T, Hofmann C, Errachid A, Heuberger A Journal article Temporal Scale-Dependent Sensitivity Analysis for Hydrological Model Parameters Using the Discrete Wavelet Transform and Active Subspaces (2021) Bittner D, Engel M, Wohlmuth B, Labat D, Chiogna G Journal article Mechanical plasticity in collective cell migration (2021) Jain S, Ladoux B, Mège RM Journal article, Review article Plasmonic Au-based junctions onto TiO2, gC3N4, and TiO2-gC3N4 systems for photocatalytic hydrogen production: Fundamentals and challenges (2021) Jimenez-Calvo P, Caps V, Keller V Journal article, Review article Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party (2021) Hayden PJ, Eikema DJ, De Wreede LC, Koster L, Kroger N, Einsele H, Minnema M, et al. Journal article Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry (2021) Hernandez-Boluda JC, Pereira A, Kroeger N, Cornelissen JJ, Finke J, Beelen D, De Witte M, et al. Journal article Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes (2021) Tsekrekos A, Vieth M, Ndegwa N, Bateman A, Flejou JF, Grabsch H, Mastracci L, et al. Journal article THE USE OF BOLUS IN POSTMASTECTOMY RADIATION THERAPY FOR BREAST CANCER: A SYSTEMATIC REVIEW (2021) Dahn H, Boersma L, De Ruysscher D, Meattini I, Offersen B, Pignol JP, Belkacemi Y, et al. Journal article EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND (2021) Berenguer M, Kremer A, Hirschfield G, Jones D, Leroy V, Adekunle F, Carbone M Conference contribution Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST (2021) Srirajaskanthan R, Pavel ME, Kulke M, Clement D, Houchard A, Keeber L, Weickert MO Journal article